Lataa...
A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells
The oncolytic herpes simplex virus (HSV) that has been approved for clinical practice and those HSVs in clinical trials are attenuated viruses, often with the neurovirulence gene γ(1)34.5 and additional genes deleted. One strategy to engineer nonattenuated oncolytic HSVs consists of retargeting the...
Tallennettuna:
| Julkaisussa: | J Virol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5411604/ https://ncbi.nlm.nih.gov/pubmed/28250120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00067-17 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|